Based on limited published evidence, BRD10 is a bromodomain-containing protein located on chromosome 9. The primary functional information derives from its identification as one of 24 genes prioritized in comprehensive genomic analyses of 9p deletion syndrome 12. BRD10 was selected based on statistical assessment of human genomic variation and spatial transcriptomics of embryonic mouse tissue, indicating relevance to craniofacial and brain development. The gene is implicated in the phenotypic manifestations affecting the majority (83%) of individuals with 9p deletion syndrome, though specific molecular functions remain to be elucidated.